Labesto, Nadia .
HRN: 27-37-03 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2025
CEFTRIAXONE 1G (VIAL)
06/23/2025
06/29/2025
IV
1gm
Q12
ABI
Checking Initial Appropriateness